APA

Nyrönen T., Pihlavisto M., Peltonen J. M., Hoffrén A. M., Varis M., Salminen T., Wurster S., Marjamäki A., Kanerva L., Katainen E., Laaksonen L., Savola J. M., Scheinin M. & Johnson M. S. (20010517). Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine. : Molecular pharmacology.

Chicago

Nyrönen T, Pihlavisto M, Peltonen J M, Hoffrén A M, Varis M, Salminen T, Wurster S, Marjamäki A, Kanerva L, Katainen E, Laaksonen L, Savola J M, Scheinin M and Johnson M S. 20010517. Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine. : Molecular pharmacology.

Harvard

Nyrönen T., Pihlavisto M., Peltonen J. M., Hoffrén A. M., Varis M., Salminen T., Wurster S., Marjamäki A., Kanerva L., Katainen E., Laaksonen L., Savola J. M., Scheinin M. and Johnson M. S. (20010517). Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine. : Molecular pharmacology.

MLA

Nyrönen T, Pihlavisto M, Peltonen J M, Hoffrén A M, Varis M, Salminen T, Wurster S, Marjamäki A, Kanerva L, Katainen E, Laaksonen L, Savola J M, Scheinin M and Johnson M S. Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine. : Molecular pharmacology. 20010517.